Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / GLAXF - ImmunoGen: Way Beyond SORAYA

GLAXF - ImmunoGen: Way Beyond SORAYA

GlaxoSmithKline Plc
  • The market recently discounted ImmunoGen due to its expectation of Mirvetuximab's SORAYA data.
  • Contrary to market belief, I view Mirve as a stellar drug for the treatment of advanced ovarian cancer.
  • I forecast a high likelihood of upcoming Mirve approval.

For further details see:

ImmunoGen: Way Beyond SORAYA
Stock Information
Company Name: GlaxoSmithKline Plc
Stock Symbol: GLAXF
Market: OTC
Website: gsk.com
Menu
GLAXF GLAXF Quote GLAXF Short GLAXF News GLAXF Articles GLAXF Message Board
Get GLAXF Alerts

News, Short Squeeze, Breakout and More Instantly...